comparemela.com
Home
Live Updates
High Risk Mds - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - High risk mds - Page 1 : comparemela.com
Study Describes Characteristics, Outcomes of Patients With Low-Risk MDS
Investigators say a better understanding of risk factors and categories can help personalize care for patients living with myelodysplastic syndrome (MDS).
Moffitt cancer center
International prognostic scoring system
Image credit
Myelodysplastic syndromes
Lr mds
Moffitt cancer center
High risk mds
Low risk mds
Imetelstat for Lower-Risk MDS: Data From the IMerge Trial
Dr Zeidan shares data presented at ASCO 2023 on the first-in-class agent Imetelstat for the treatment of lower-risk MDS.
Myelodysplastic syndromes
Recent updates
Evolving treatment paradigms
Data from
Myelodysplastic syndromes recent updates
Treatment evolution myelodysplastic syndromes
Mds management
Asco 2023
2023 asco annual meeting
American society of clinical oncology
Mds symptoms
Mds diagnosis
Mds presentations
High risk mds
Low risk mds
Luspatercept for Lower-Risk MDS: Data From the COMMANDS Trial
Rami Komrokji, MD, summarizes data presented at ASCO 2023 from the COMMANDS trial on the role of luspatercept in lower-risk MDS.
Myelodysplastic syndromes
Recent updates
Evolving treatment paradigms
Data from
Myelodysplastic syndromes recent updates
Treatment evolution myelodysplastic syndromes
Mds management
Asco 2023
2023 asco annual meeting
American society of clinical oncology
Mds symptoms
Mds diagnosis
Mds presentations
High risk mds
Low risk mds
ESA Outcomes by SF3B1 Mutation Status in Lower-Risk MDS
Dr Madanat reviews data from an abstract presented at ASCO 2023 on the outcomes of ESA therapy in patients with SF3B1-mutated lower-risk MDS.
Myelodysplastic syndromes
Recent updates
Evolving treatment paradigms
Myelodysplastic syndromes recent updates
Treatment evolution myelodysplastic syndromes
Mds management
Asco 2023
2023 asco annual meeting
American society of clinical oncology
Mds symptoms
Mds diagnosis
Mds presentations
High risk mds
Low risk mds
Patient Profile: A 79-Year-Old Man With Lower-Risk MDS and a KRAS Mutation
Yazan Madanat, MD, presents the patient profile of a transfusion-dependent 79-year-old man with lower-risk MDS and a KRAS mutation.
Yazan madanat
Myelodysplastic syndromes
Recent updates
Evolving treatment paradigms
Year old man with lower risk
Myelodysplastic syndromes recent updates
Treatment evolution myelodysplastic syndromes
Mds management
Asco 2023
2023 asco annual meeting
American society of clinical oncology
Mds symptoms
Mds diagnosis
Mds presentations
High risk mds
Low risk mds
vimarsana © 2020. All Rights Reserved.